Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Cancers|August 28, 2025
Exogenous Estrogens as Breast Cancer Risk Factors: A PerspectiveParth Malik, Tapan Kumar MukherjeeMethods (San Diego, Calif.)|February 3, 2022
Immunological methods for the determination of AGE-RAGE axis generated glutathionylated and carbonylated proteins as oxidative stress markersParth Malik, Tapan Kumar MukherjeeMolecular Biology Reports|September 12, 2022
Applications of CRISPR/Cas technology against drug-resistant lung cancers: an updateMayank Chaudhary, Pooja Sharma, Tapan Kumar MukherjeeIndian Heart Journal|June 19, 2016
Prevalence, awareness, and control of hypertension in the slums of KolkataSuvro Banerjee, Tapan Kumar Mukherjee, Srabashi BasuCancers|January 11, 2022
Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A PerspectiveRadhashree Maitra, Parth Malik, Tapan Kumar MukherjeeCOPD|October 7, 2021
Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGEParth Malik, John R Hoidal, Tapan Kumar MukherjeeCurrent Cancer Drug Targets|July 28, 2026
Overcoming Drug Resistance in Breast Cancer: Advances in Targeted and Combination TherapiesSandip Mondal, Manish Kumar Gautam, Tapan Kumar MukherjeeJournal of Molecular Modeling|October 21, 2016
Immunogenic decapeptide in melanoma immunotherapyNavnit Kumar Mishra, Anil Kumar Sharma, Tapan Kumar MukherjeePharmaceutics|January 21, 2023
Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer TreatmentRuma Rani, Parth Malik, Sunena Dhania, et al.Current Drug Targets|November 21, 2018
The Potential of Receptor for Advanced Glycation End Products (RAGE) as a Therapeutic Target for Lung Associated DiseasesTejinder Pal Khaket, Sun Chul Kang, Tapan Kumar MukherjeePageof 3